TP53 and cancer: Sulanemadlin (ALRN-6924), is the first cell-permeating, stabilized α-helical peptide which mimics the N-terminal domain of the p53 and binds with high affinity to both MDM2 and MDM4 to activate p53 signaling in cancer cells [124].